We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Hit With Untitled Letter for Misleading Xarelto Ad
J&J Hit With Untitled Letter for Misleading Xarelto Ad
June 28, 2013
The FDA flagged a direct-to-consumer advertisement for Johnson & Johnson’s (J&J) blood-thinner Xarelto as misleading, handing the drugmaker a second untitled letter in as many months.